C4BP Antibodies

Santa Cruz Biotechnology features a diverse variety of C4BP monoclonal antibodies for investigating complement component 4-binding protein (C4BP). C4BP monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C4BP plays a critical role in the regulation of the complement system, which is essential for immune response and inflammation. By binding to complement component C4b, C4BP prevents the formation of the C3 convertase, thereby inhibiting complement activation and protecting host tissues from damage. Understanding C4BP function is vital for elucidating its involvement in various diseases, including autoimmune disorders and infections. Researchers can explore C4BP's role in complement regulation through multiple experimental approaches. Advanced research techniques using C4BP monoclonal antibodies enable detailed analysis of protein interactions and signaling pathways. Investigating C4BP expression patterns helps reveal its distribution across different tissues and cell types. Santa Cruz Biotechnology monoclonal antibodies for C4BP support researchers worldwide in advancing our understanding of complement system regulation and immune response mechanisms.